These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

368 related items for PubMed ID: 10945849

  • 21. Comparison of receptor mechanisms and efficacy requirements for delta-agonist-induced convulsive activity and antinociception in mice.
    Broom DC, Nitsche JF, Pintar JE, Rice KC, Woods JH, Traynor JR.
    J Pharmacol Exp Ther; 2002 Nov; 303(2):723-9. PubMed ID: 12388657
    [Abstract] [Full Text] [Related]

  • 22. Opioid receptor subtypes differentially modulate serotonin efflux in the rat central nervous system.
    Tao R, Auerbach SB.
    J Pharmacol Exp Ther; 2002 Nov; 303(2):549-56. PubMed ID: 12388635
    [Abstract] [Full Text] [Related]

  • 23. Role of delta opioid receptors in the reinforcing and discriminative stimulus effects of cocaine in rhesus monkeys.
    Negus SS, Mello NK, Portoghese PS, Lukas SE, Mendelson JH.
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1245-56. PubMed ID: 7791097
    [Abstract] [Full Text] [Related]

  • 24. Characterization of antinociception to opioid receptor selective agonists after antisense oligodeoxynucleotide-mediated "knock-down" of opioid receptor in vivo.
    Bilsky EJ, Bernstein RN, Hruby VJ, Rothman RB, Lai J, Porreca F.
    J Pharmacol Exp Ther; 1996 Apr; 277(1):491-501. PubMed ID: 8613959
    [Abstract] [Full Text] [Related]

  • 25. Nitrocinnamoyl and chlorocinnamoyl derivatives of dihydrocodeinone: in vivo and in vitro characterization of mu-selective agonist and antagonist activity.
    McLaughlin JP, Hill KP, Jiang Q, Sebastian A, Archer S, Bidlack JM.
    J Pharmacol Exp Ther; 1999 Apr; 289(1):304-11. PubMed ID: 10087018
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Effects of beta-funaltrexamine on dose-effect curves for heroin self-administration in rats: comparison with alteration of [3H]DAMGO binding to rat brain sections.
    Martin TJ, DeMontis MG, Kim SA, Sizemore GM, Dworkin SI, Smith JE.
    Drug Alcohol Depend; 1998 Oct 01; 52(2):135-47. PubMed ID: 9800143
    [Abstract] [Full Text] [Related]

  • 31. Modulation of nociception by microinjection of delta-1 and delta-2 opioid receptor ligands in the ventromedial medulla of the rat.
    Thorat SN, Hammond DL.
    J Pharmacol Exp Ther; 1997 Dec 01; 283(3):1185-92. PubMed ID: 9399992
    [Abstract] [Full Text] [Related]

  • 32. Behavioral effects of the delta-selective opioid agonist SNC80 and related compounds in rhesus monkeys.
    Negus SS, Gatch MB, Mello NK, Zhang X, Rice K.
    J Pharmacol Exp Ther; 1998 Jul 01; 286(1):362-75. PubMed ID: 9655881
    [Abstract] [Full Text] [Related]

  • 33. Chronic muscle pain induced by repeated acid Injection is reversed by spinally administered mu- and delta-, but not kappa-, opioid receptor agonists.
    Sluka KA, Rohlwing JJ, Bussey RA, Eikenberry SA, Wilken JM.
    J Pharmacol Exp Ther; 2002 Sep 01; 302(3):1146-50. PubMed ID: 12183674
    [Abstract] [Full Text] [Related]

  • 34. Contribution of spinal mu(1)-opioid receptors and dynorphin B to the antinociception induced by Tyr-d-Arg-Phe-Sar.
    Mizoguchi H, Ito K, Watanabe H, Watanabe C, Katsuyama S, Fujimura T, Sakurada T, Sakurada S.
    Peptides; 2006 Nov 01; 27(11):2786-93. PubMed ID: 16919848
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Microinjection of the delta-opioid receptor selective antagonist naltrindole 5'-isothiocyanate site specifically affects cocaine self-administration in rats responding under a progressive ratio schedule of reinforcement.
    Ward SJ, Roberts DC.
    Behav Brain Res; 2007 Aug 22; 182(1):140-4. PubMed ID: 17572514
    [Abstract] [Full Text] [Related]

  • 37. Characterization of kappa and delta opioid receptors in isolated organs by using type/subtype selective agonists and antagonists.
    Makó E, Rónai AZ.
    Med Sci Monit; 2001 Aug 22; 7(3):350-6. PubMed ID: 11386008
    [Abstract] [Full Text] [Related]

  • 38. Antinociceptive and behavioral effects of synthetic deltorphin analogs.
    Negri L, Noviello L, Noviello V.
    Eur J Pharmacol; 1996 Jan 18; 296(1):9-16. PubMed ID: 8720471
    [Abstract] [Full Text] [Related]

  • 39. Absence of conditioned place preference or reinstatement with bivalent ligands containing mu-opioid receptor agonist and delta-opioid receptor antagonist pharmacophores.
    Lenard NR, Daniels DJ, Portoghese PS, Roerig SC.
    Eur J Pharmacol; 2007 Jul 02; 566(1-3):75-82. PubMed ID: 17383633
    [Abstract] [Full Text] [Related]

  • 40. Role of opioid receptors in the spinal antinociceptive effects of neuropeptide FF analogues.
    Gouardères C, Jhamandas K, Sutak M, Zajac JM.
    Br J Pharmacol; 1996 Feb 02; 117(3):493-501. PubMed ID: 8821539
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.